N/A N=180 Randomized Single-blind Prevention

Development of a Tailored HIV Prevention Intervention for Young Men

HIV Infections

Bottom Line

View on ClinicalTrials.gov: NCT02842060 ↗

Enrolled (actual)

180

Serious AEs

0.0%

Results posted

Jul 2019

Primary outcome: Primary: Number of Participants With Change in Number of Risky Sexual Partnerships — 32; 24; 88; 36 Participants

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: myDEx (Behavioral); NTHP (Behavioral)
Age: Adult · 18+ yrs
Sex: Male
Sponsor: University of Pennsylvania
Primary completion: May 2017

Outcome Measures

Outcome	Result	p-value
PRIMARY Number of Participants With Change in Number of Risky Sexual Partnerships	32; 24; 88; 36	—
PRIMARY Number of Participants With Change in HIV Testing Behavior	56; 29	—
SECONDARY Change in Self-efficacy Motivations to Engage in HIV Prevention Behaviors	1.93; 1.99	—
SECONDARY Changes in Psychological Well-being	1.84; 1.93	—

Summary

This study uses an interactive design and development process to develop tailored messages that align YMSM's relationship experiences and desires with HIV prevention strategies. The study includes a tailored online prevention, intervention, as well as an attention control non--tailored HIV prevention (NTHP) comparison intervention. The pilot RCT will compare the intervention (N=120) to NTHP (N=60) to assess intervention feasibility and acceptability, and gather preliminary behavioral data to inform a subsequent application. Follow-up assessments will be collected at thirty (30), sixty (60), and ninety (90) days post-intervention.

Eligibility Criteria

Inclusion Criteria

Cis-gender male
Self-report as being single
Self report as HIV-negative at baseline
Speak and read English
Report unprotected anal intercourse with a male partner in prior six (6) months
Have access to computer or smartphone device

Exclusion Criteria

Transgender identity
HIV positive diagnosis
Not residing in the United States
Does not engage in male-to-male sexual behavior

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02842060). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.